AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Advertisement

Banner image featuring company logo

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Their purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.

 

IN Control education series

 

IN Control clinical audit: INsulin INitiation and INtensification to avoid clinical INertia

Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.